According to a report by Intel Market Research, the global Dabigatran Etexilate API Market was valued at USD 158.0 million in 2025, estimated at USD 160.0 million in 2026, and is projected to reach USD 183.0 million by 2034, representing a 1.7% CAGR during 2026–2034. Dabigatran etexilate API supports direct-thrombin-inhibitor products used for stroke prevention in nonvalvular atrial...
According to a report by Intel Market Research, the global Omeprazole API Market was valued at USD 157.5 million in 2025, estimated at USD 160.5 million in 2026, and is projected to reach USD 187.9 million by 2034, representing a 2.0% CAGR during 2026–2034. Omeprazole is a mature, high-volume proton-pump inhibitor API used across prescription and over-the-counter acid-suppression...
According to a report by Intel Market Research, the global Pantoprazole Sodium API Market was valued at USD 134.0 million in 2025, estimated at USD 136.8 million in 2026, and is projected to reach USD 163.5 million by 2034, representing a 2.3% CAGR during 2026–2034. Pantoprazole sodium is a mature proton pump inhibitor API used across chronic oral treatment and hospital intravenous...
According to a report by Intel Market Research, the global Esomeprazole Magnesium API Market was valued at USD 112.5 million in 2025, estimated at USD 114.8 million in 2026, and is projected to reach USD 139.0 million by 2034, representing a 2.4% CAGR during 2026–2034. Esomeprazole magnesium is a mature proton pump inhibitor API used in prescription and over-the-counter...
According to a report by Intel Market Research, the global Ondansetron Hydrochloride API Market was valued at USD 98.0 million in 2025, estimated at USD 100.2 million in 2026, and is projected to reach USD 126.8 million by 2034, representing a 3.0% CAGR during 2026–2034. Ondansetron hydrochloride is a mature 5-HT3 antagonist API used primarily in oncology supportive care and for...
According to a report by Intel Market Research, the global Famotidine API Market was valued at USD 84.0 million in 2025, estimated at USD 85.7 million in 2026, and is projected to reach USD 104.6 million by 2034, representing a 2.5% CAGR during 2026–2034. Famotidine is a mature H2-receptor antagonist API used across prescription, over-the-counter and hospital acid-suppression products....
According to a report by Intel Market Research, the global Budesonide API Market was valued at USD 168.0 million in 2025 and is estimated to reach USD 173.0 million in 2026. The market is projected to reach USD 229.0 million by 2034, representing a CAGR of 3.6% during 2026–2034. Budesonide is a high-value corticosteroid API used across inhaled, oral and nasal formulations, with demand...
According to a report by Intel Market Research, the global Fluticasone Propionate API Market was valued at USD 142.0 million in 2025 and is estimated to reach USD 146.0 million in 2026. The market is projected to reach USD 189.0 million by 2034, representing a CAGR of 3.3% during 2026–2034. Fluticasone propionate is a corticosteroid API used in inhaled, intranasal and topical dosage...
According to a report by Intel Market Research, the global Montelukast Sodium API Market was valued at USD 96.0 million in 2025 and is estimated to reach USD 98.6 million in 2026. The market is projected to reach USD 126.0 million by 2034, representing a CAGR of 3.1% during 2026–2034. Montelukast sodium is a mature oral respiratory API used in asthma maintenance, prevention of...
According to a report by Intel Market Research, the global Cetirizine Hydrochloride API Market was valued at USD 82.0 million in 2025 and is estimated to reach USD 84.3 million in 2026. The market is projected to reach USD 108.0 million by 2034, representing a CAGR of 3.1% during 2026–2034. Cetirizine hydrochloride is a mature second-generation antihistamine API used across prescription...
According to a report by Intel Market Research, the global Loratadine API Market was valued at USD 76.0 million in 2025 and is estimated to reach USD 78.2 million in 2026. The market is projected to reach USD 100.8 million by 2034, representing a CAGR of 3.2% during 2026–2034. Loratadine API is a mature second-generation antihistamine input used in prescription and over-the-counter...
According to a report by Intel Market Research, the global Cephalexin API Market was valued at USD 367.8 million in 2025, estimated at USD 380.5 million in 2026, and projected to reach USD 505.0 million by 2034, representing a 3.60% CAGR during 2026–2034. Cephalexin is a first-generation oral cephalosporin API used across capsules, tablets and pediatric oral suspensions. Its Access-group...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek
